Navigation Links
Prodigy Health Supplier Partners with Stason Pharmaceuticals to Help Relieve U.S. Drug Shortages
Date:6/26/2012

AUSTIN, Texas, June 26, 2012 /PRNewswire/ -- Prodigy Health Supplier entered a Joint Venture with Stason Pharmaceuticals to bring a diverse line of quality generic pharmaceuticals to the U.S. market. This relationship represents a combined commitment to providing the highest quality generic drugs with a consistent supply and a competitive price.

The partnership supports robust research and development with 30 PhDs on staff and over 120 people in that department. Core generic therapeutic categories include oncology, central nervous system (CNS), cardiovascular and dermatologic indications. Delivery mechanisms for the drugs include capsules and oral solids as well as new delivery mechanisms.

Bryan Sanders, president of Prodigy Health Supplier, states, "Quality manufacturing in Stason will provide excellent long term value to our business as well as the generic pharmaceutical market. Three of our current registrations are found on the national FDA shortage list and we are dedicated to bringing these products to market as soon as possible to help alleviate this strain. There are 7 drugs in our present pipeline that will be released over the next two years and we are evaluating additional items on the shortage list for potential registration and production."

Prodigy Health Supplier Corporation (PHS), a privately held company, was established in 2001 and is based in Austin, Texas. Since inception PHS has been a consistent and dependable supplier in the bio-pharmaceutical industry and has grown into one of the leading suppliers of plasma derivatives and injectables in the United States. PHS launched their generics division in 2010 and partners with proven manufacturers to provide a strong portfolio of generic drugs to the U.S. market. More information about PHS can be found at www.phscorporation.com.

Stason Pharmaceuticals, Inc., established in 1994 and based in Irvine, CA is a privately-held, global pharmaceutical company involved in drug development, manufacturing, importation/exportation, licensing and marketing of both generic and branded products. The company's primary area of development is in the area of oncology, and supportive products for the treatment of side effects related to cancer therapy. Additional therapeutic areas include cardiovascular, central nervous system, autoimmune and endocrine disorders. Additional information about Stason can be found at www.stasonpharma.com.


'/>"/>
SOURCE Prodigy Health Supplier Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan.
2. HealthWarehouse.com and Northwest Physicians Network Partner to Provide Exclusive Discount Pharmacy Services to Patients
3. Double Helix Joins McCann Health
4. Prostate Cancer and Bone Health
5. HealthWarehouse.com Reports 82% Year-Over-Year Revenue Growth
6. Billians HealthDATA Expands Market Coverage to Include Physician Group Practices
7. Vocollect Healthcare Systems And Prime Care Technologies Bring AccuNurse Key Performance Metrics To Long-Term Care Providers Via primeVIEW Digital Dashboard
8. U.S. News & World Report and Pharmacy Times Announce "Top Recommended Health Products"
9. ZO Skin Health, Inc. Sues Third-Party Pirates Over Illegal Sales of its Products
10. Lifescript Launches New Online Asthma Health Center
11. Gateway Foundation Warns K2 is Bad News: K2 Poses Serious Health Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)...  The blood testing market in China ... Information and The Freedonia Group in a recent report.  ... The healthcare research firm said that China ... stations and in improving testing at the provincial level.  ... Blood Testing Market in China , which ...
(Date:4/28/2016)... , April 28, 2016 Dr. ... and Ste phen ... ArisGlobal®, a leading provider of cloud-based software solutions for life ... Pharmacovigilance team to bring a wealth of insight to a growing ... pharmacovigilance knowledge. George Phillips joined ArisGlobal in ...
(Date:4/28/2016)... 28, 2016  ValGenesis, Inc., the market ... (VLMS) today announced that a prominent world ... of chronic kidney failure has selected ValGenesis ... corporate validation process. The global medical device ... to manage their validation processes electronically. Upon ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... ... As directed by its board of directors during its April 26 meeting, ... certified nurse practitioners (CNP) to practice to the full scope of their license without ... years and 3,600 hours. , In addition, HAP supports CNPs who are licensed in ...
(Date:5/2/2016)... LINCOLN, R.I. (PRWEB) , ... May 02, 2016 ... ... , an educational website to help consumers better understand life insurance throughout various ... helpful resources, including an easy-to-use life insurance needs calculator and content specific to ...
(Date:5/2/2016)... ... May 02, 2016 , ... Dr. Philip Shindler, ... with same day treatments. In the past, many necessary dental treatments could require multiple ... with multiple anesthetic shots and extra chair time. Not only could this be inconvenient, ...
(Date:5/2/2016)... ... 2016 , ... Further establishing itself as a leader in natural pet products ... Boxes were selected from over 1,000 entrants as a winner and recipient of the ... chews for dogs are a favorite product among pet-parents worldwide, as each whimsical knobby ...
(Date:5/2/2016)... ... May 02, 2016 , ... ... that many commonly used prescription medications, including anxiolytics, painkillers, antidepressants and cholesterol-lowering ... risks, Novus Medical Detox Center —a leading Florida-based drug treatment facility—advises ...
Breaking Medicine News(10 mins):